DCM
EWTX icon

Driehaus Capital Management’s Edgewise Therapeutics EWTX Stock Holding History

Driehaus Capital Management’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$141M Buy
4,477,942
+286,749
+7% +$8.27M 1.04% 12
2025
Q4 		$104M Buy
4,191,193
+1,962,908
+88% +$39.4M 0.71% 32
2025
Q3 		$36.1M Buy
2,228,285
+126,504
+6% +$1.79M 0.26% 131
2025
Q2 		$27.6M Buy
2,101,781
+726,039
+53% +$10.5M 0.22% 145
2025
Q1 		$30.3M Sell
1,375,742
-118,049
-8% -$3.1M 0.29% 110
2024
Q4 		$39.9M Sell
1,493,791
-459,633
-24% -$14.6M 0.33% 101
2024
Q3 		$52.1M Buy
1,953,424
+693,032
+55% +$13.8M 0.45% 70
2024
Q2 		$22.7M Sell
1,260,392
-7,427
-0.6% -$130K 0.22% 128
2024
Q1 		$23.1M Buy
1,267,819
+872,750
+221% +$13.9M 0.23% 131
2023
Q4 		$4.32M Buy
+395,069
New +$2.77M 0.05% 274

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Driehaus Capital Management's EWTX Position: Q1 2026 in Review

Driehaus Capital Management increased its Edgewise Therapeutics (EWTX) stake by 6.8% in Q1 2026, buying an estimated $8.27M and bringing the position to 4,477,942 shares worth $141M. The position accounts for 1.04% of the portfolio, ranked #12.

Driehaus Capital Management first reported a position in EWTX in Q4 2023 and has held it in 10 quarters since. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

  • Driehaus Capital Management held 4,477,942 shares of Edgewise Therapeutics worth $141M as of Q1 2026.
  • Driehaus Capital Management bought 286,749 Edgewise Therapeutics shares in Q1 2026, an estimated $8.27M.
  • Edgewise Therapeutics made up 1.04% of Driehaus Capital Management's portfolio in Q1 2026, its #12 holding.
  • Driehaus Capital Management first reported a position in Edgewise Therapeutics in Q4 2023 and has held it in 10 quarters since.
  • 214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on Driehaus Capital Management's 13F filing for Q1 2026, filed 15 May 2026.